Assembly Biosciences, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $22.1M | $191.1M | $45.6M |
| FY2022 | $19.1M | $101.8M | $52.4M |
| FY2023 | $95.7M | $136.8M | $19.8M |
| FY2024 | $85.8M | $119.2M | $38.3M |
| FY2025 | $50.8M | $257.6M | $58.5M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $22.1M | $191.1M | $45.6M |
| FY2022 | $19.1M | $101.8M | $52.4M |
| FY2023 | $95.7M | $136.8M | $19.8M |
| FY2024 | $85.8M | $119.2M | $38.3M |
| FY2025 | $50.8M | $257.6M | $58.5M |